Literature DB >> 19339764

Bipolar disorder: from genes to behavior pathways.

Keri Martinowich1, Robert J Schloesser, Husseini K Manji.   

Abstract

Bipolar disorder (BPD) is a devastating illness that is characterized by recurrent episodes of mania and depression. In addition to these cyclic episodes, individuals with BPD exhibit changes in psychovegetative function, cognitive performance, and general health and well being. In this article we draw from neuroimaging findings in humans, postmortem data, and human genetic and pharmacological studies as well as data from animal models of behavior to discuss the neurobiology of BPD. We conclude with a synthesis of where the field stands and with suggestions and strategies for future areas of study to further increase our conceptual understanding of this complex illness.

Entities:  

Mesh:

Year:  2009        PMID: 19339764      PMCID: PMC2662565          DOI: 10.1172/JCI37703

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  137 in total

Review 1.  Synapsins as regulators of neurotransmitter release.

Authors:  S Hilfiker; V A Pieribone; A J Czernik; H T Kao; G J Augustine; P Greengard
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-02-28       Impact factor: 6.237

Review 2.  Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.

Authors:  Todd D Gould; Husseini K Manji
Journal:  Neuropsychopharmacology       Date:  2005-07       Impact factor: 7.853

3.  The increasing medical burden in bipolar disorder.

Authors:  David J Kupfer
Journal:  JAMA       Date:  2005-05-25       Impact factor: 56.272

Review 4.  Wnt factors in axonal remodelling and synaptogenesis.

Authors:  P C Salinas
Journal:  Biochem Soc Symp       Date:  1999

Review 5.  Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?

Authors:  De-Maw Chuang
Journal:  Crit Rev Neurobiol       Date:  2004

6.  Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons.

Authors:  E Chalecka-Franaszek; D M Chuang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

7.  Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder.

Authors:  G Rajkowska; A Halaris; L D Selemon
Journal:  Biol Psychiatry       Date:  2001-05-01       Impact factor: 13.382

8.  The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers.

Authors:  Rulun Zhou; Neil A Gray; Peixiong Yuan; Xiaoxia Li; Jingshan Chen; Guang Chen; Patricia Damschroder-Williams; Jing Du; Lei Zhang; Husseini K Manji
Journal:  J Neurosci       Date:  2005-05-04       Impact factor: 6.167

9.  Heritability estimates for psychotic disorders: the Maudsley twin psychosis series.

Authors:  A G Cardno; E J Marshall; B Coid; A M Macdonald; T R Ribchester; N J Davies; P Venturi; L A Jones; S W Lewis; P C Sham; I I Gottesman; A E Farmer; P McGuffin; A M Reveley; R M Murray
Journal:  Arch Gen Psychiatry       Date:  1999-02

10.  AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test.

Authors:  Todd D Gould; Haim Einat; Ratan Bhat; Husseini K Manji
Journal:  Int J Neuropsychopharmacol       Date:  2004-07-26       Impact factor: 5.176

View more
  35 in total

Review 1.  Switching to hypomania and mania: differential neurochemical, neuropsychological, and pharmacologic triggers and their mechanisms.

Authors:  Jun Chen; Yiru Fang; David E Kemp; Joseph R Calabrese; Keming Gao
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

2.  Regulation of glycogen synthase kinase-3 during bipolar mania treatment.

Authors:  Xiaohong Li; Min Liu; Zhuoji Cai; Gang Wang; Xiaohua Li
Journal:  Bipolar Disord       Date:  2010-11       Impact factor: 6.744

3.  Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder.

Authors:  Sven Cichon; Thomas W Mühleisen; Franziska A Degenhardt; Manuel Mattheisen; Xavier Miró; Jana Strohmaier; Michael Steffens; Christian Meesters; Stefan Herms; Moritz Weingarten; Lutz Priebe; Britta Haenisch; Michael Alexander; Jennifer Vollmer; René Breuer; Christine Schmäl; Peter Tessmann; Susanne Moebus; H-Erich Wichmann; Stefan Schreiber; Bertram Müller-Myhsok; Susanne Lucae; Stéphane Jamain; Marion Leboyer; Frank Bellivier; Bruno Etain; Chantal Henry; Jean-Pierre Kahn; Simon Heath; Marian Hamshere; Michael C O'Donovan; Michael J Owen; Nick Craddock; Markus Schwarz; Helmut Vedder; Jutta Kammerer-Ciernioch; Andreas Reif; Johanna Sasse; Michael Bauer; Martin Hautzinger; Adam Wright; Philip B Mitchell; Peter R Schofield; Grant W Montgomery; Sarah E Medland; Scott D Gordon; Nicholas G Martin; Omar Gustafsson; Ole Andreassen; Srdjan Djurovic; Engilbert Sigurdsson; Stacy Steinberg; Hreinn Stefansson; Kari Stefansson; Lejla Kapur-Pojskic; Liliana Oruc; Fabio Rivas; Fermín Mayoral; Alexander Chuchalin; Gulja Babadjanova; Alexander S Tiganov; Galina Pantelejeva; Lilia I Abramova; Maria Grigoroiu-Serbanescu; Carmen C Diaconu; Piotr M Czerski; Joanna Hauser; Andreas Zimmer; Mark Lathrop; Thomas G Schulze; Thomas F Wienker; Johannes Schumacher; Wolfgang Maier; Peter Propping; Marcella Rietschel; Markus M Nöthen
Journal:  Am J Hum Genet       Date:  2011-02-25       Impact factor: 11.025

4.  A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.

Authors:  Nancy Diazgranados; Lobna Ibrahim; Nancy E Brutsche; Andrew Newberg; Phillip Kronstein; Sami Khalife; William A Kammerer; Zenaide Quezado; David A Luckenbaugh; Giacomo Salvadore; Rodrigo Machado-Vieira; Husseini K Manji; Carlos A Zarate
Journal:  Arch Gen Psychiatry       Date:  2010-08

5.  Preventive Effect of Cecropia pachystachya Against Ketamine-Induced Manic Behavior and Oxidative Stress in Rats.

Authors:  Marta Gazal; Fernanda N Kaufmann; Bruna A Acosta; Pathise Souto Oliveira; Matheus R Valente; Caroline Flach Ortmann; Régis Sturbelle; Claiton L Lencina; Francieli M Stefanello; Manuella P Kaster; Flávio Henrique Reginatto; Gabriele Ghisleni
Journal:  Neurochem Res       Date:  2015-05-22       Impact factor: 3.996

6.  Early life stress exacerbates cognitive dysfunction induced by d-amphetamine: amelioration by valproic acid.

Authors:  Rose Mary Carvalho Pinheiro; Maria Noêmia Martins de Lima; Gabriel Rodrigo Fries; Vanessa Athaíde Garcia; Juliana Presti-Torres; Luis Henrique Hallmenschlager; Luisa Azambuja Alcalde; Rafael Roesler; Monica Levy Andersen; João Quevedo; Flávio Kapczinski; Nadja Schröder
Journal:  J Neural Transm (Vienna)       Date:  2012-01-05       Impact factor: 3.575

7.  Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances.

Authors:  Abigail Polter; Eléonore Beurel; Sufen Yang; Rakesha Garner; Ling Song; Courtney A Miller; J David Sweatt; Lori McMahon; Alfred A Bartolucci; Xiaohua Li; Richard S Jope
Journal:  Neuropsychopharmacology       Date:  2010-03-31       Impact factor: 7.853

Review 8.  Cross-species assessments of motor and exploratory behavior related to bipolar disorder.

Authors:  Brook L Henry; Arpi Minassian; Jared W Young; Martin P Paulus; Mark A Geyer; William Perry
Journal:  Neurosci Biobehav Rev       Date:  2010-04-14       Impact factor: 8.989

9.  Antimanic Efficacy of a Novel Kv3 Potassium Channel Modulator.

Authors:  Puja K Parekh; Michelle M Sidor; Andrea Gillman; Darius Becker-Krail; Letizia Bettelini; Roberto Arban; Giuseppe S Alvaro; Erika Zambello; Chiara Mutinelli; Yanhua Huang; Charles H Large; Colleen A McClung
Journal:  Neuropsychopharmacology       Date:  2017-08-31       Impact factor: 7.853

10.  SorCS2 is required for BDNF-dependent plasticity in the hippocampus.

Authors:  S Glerup; U Bolcho; S Mølgaard; S Bøggild; C B Vaegter; A H Smith; J L Nieto-Gonzalez; P L Ovesen; L F Pedersen; A N Fjorback; M Kjolby; H Login; M M Holm; O M Andersen; J R Nyengaard; T E Willnow; K Jensen; A Nykjaer
Journal:  Mol Psychiatry       Date:  2016-07-26       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.